tiprankstipranks
Pharmaust Limited (DE:ECQ0)
FRANKFURT:ECQ0
Germany Market
ECQ0
Pharmaust Limited
RESEARCH TOOLSreports
Want to see DE:ECQ0 full AI Analyst Report?

Pharmaust Limited (ECQ0) Stock News & Sentiment

3 Followers
Neurizon Therapeutics Discloses Director Departure and Remaining Equity Interests
Premium
Company Announcements
Neurizon Therapeutics Discloses Director Departure and Remaining Equity Interests
53m ago
Neurizon Therapeutics appoints Dr Ross Murdoch as new director
Premium
Company Announcements
Neurizon Therapeutics appoints Dr Ross Murdoch as new director
54m ago
Neurizon Targets Investor Visibility with NUZ-001 ALS Update at Microcap Conference
Premium
Company Announcements
Neurizon Targets Investor Visibility with NUZ-001 ALS Update at Microcap Conference
1d ago
Neurizon steps up investor outreach with NUZ-001 ALS briefing series
Premium
Company Announcements
Neurizon steps up investor outreach with NUZ-001 ALS briefing series
12d ago
Neurizon Therapeutics Seeks Quotation of 4.18 Million New Shares on ASX
Premium
Company Announcements
Neurizon Therapeutics Seeks Quotation of 4.18 Million New Shares on ASX
12d ago
Neurizon Advances NUZ-001 in HEALEY ALS Trial and Fortifies Balance Sheet
Premium
Company Announcements
Neurizon Advances NUZ-001 in HEALEY ALS Trial and Fortifies Balance Sheet
12d ago
Neurizon Clears 33.2m New Shares After Entitlement Offer Shortfall Placement
Premium
Company Announcements
Neurizon Clears 33.2m New Shares After Entitlement Offer Shortfall Placement
21d ago
More DE:ECQ0 News >

ECQ0 News on the Web

Neurizon launches national investor briefings as ALS program enters key phase
TipRanks News
Neutral
Health Check: US report ponders the dark side of dollar-driven medical AI
StockHead
Neutral
Neurizon Raises A$2.7m via Entitlement Offer Shortfall to Advance ALS Drug NUZ-001
TipRanks News
Neutral
Health Check: Telix strikes surprise $3 billion-plus headline deal to develop next-gen therapies
StockHead
Neutral
Long Shortz with Neurizon Therapeutics: NUZ-001 builds momentum in ALS trial with new data
StockHead
Bullish
Neurizon Director Increases Stake Through $150,000 Share Placement
TipRanks News
Neutral
Neurizon Issues Director Shares, Affirms Compliance and Transparency
TipRanks News
Neutral
Neurizon Therapeutics Seeks ASX Quotation for 9.5 Million New Shares
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
DE:ECQ0
Sector Average
Media Buzz
This Week3 articles
Weekly Average1.5 articles
News Sentiment
This Week50%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:ECQ0’s Media Buzz Sentiment?
3 articles about DE:ECQ0 were published this week. In an average week, 1.5 articles are published.
    What is DE:ECQ0’s weekly average amount of articles?
    In an average week, 1.5 articles about DE:ECQ0 are published.
      What is DE:ECQ0’s News Sentiment?
      50% of articles about DE:ECQ0 were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week